Quanterix (QTRX) Income from Continuing Operations (2017 - 2026)
Quanterix (QTRX) posted Income from Continuing Operations of 17541000.0 for Q1 2026, up 24.12% on a QoQ basis from 23117000.0 in Q4 2025, and up 14.45% year-over-year from 15326231.05 in Q1 2025.
Quanterix (QTRX) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Quanterix's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 17541000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 14.45% year-over-year to 17541000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 104188000.0 (down 117.64% YoY) and the FY2025 annual result came in at 107150000.0, down 178.09% from the prior year.
- Income from Continuing Operations was 17541000.0 for Q1 2026 at Quanterix, up from 23117000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5551000.0 in Q2 2023 and bottomed at 36550000.0 in Q3 2022.
- A 5-year average of 17126529.41 and a median of 17541000.0 in 2026 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 81.63% — and 2025, when it slumped 306.29%.
- Quanterix's Income from Continuing Operations stood at 18198000.0 in 2022, then surged by 51.57% to 8813000.0 in 2023, then slumped by 31.94% to 11628000.0 in 2024, then slumped by 98.8% to 23117000.0 in 2025, then advanced by 24.12% to 17541000.0 in 2026.
- Business Quant data shows QTRX's Income from Continuing Operations at 17541000.0 in Q1 2026, 23117000.0 in Q4 2025, and 33517000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -17.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.54 Mn |
| Dec 31, 2025 | -23.12 Mn |
| Sep 30, 2025 | -33.52 Mn |
| Jun 30, 2025 | -30.01 Mn |
| Mar 31, 2025 | -20.50 Mn |
| Dec 31, 2024 | -11.63 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Jun 30, 2024 | -7.39 Mn |
| Mar 31, 2024 | -11.16 Mn |
| Dec 31, 2023 | -8.81 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -7.27 Mn |
| Dec 31, 2022 | -18.20 Mn |
| Sep 30, 2022 | -36.55 Mn |
| Jun 30, 2022 | -26.91 Mn |
| Mar 31, 2022 | -17.92 Mn |
| Dec 31, 2021 | -17.89 Mn |
| Sep 30, 2021 | -15.66 Mn |
| Jun 30, 2021 | -11.90 Mn |